Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

News Daily News

AHA/ACC and Others Issue PAD Guideline Update With Focus on Collaborative Care

L.A. McKeown

May 17, 2024

News Daily News

Ischemic Stroke After LAA Closure May Be Less Severe Than on DOACs

Michael O'Riordan

November 27, 2023

News Daily News

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

L.A. McKeown

July 11, 2023

News Daily News

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

L.A. McKeown

June 29, 2022

News Daily News

Subclinical Thrombosis After TAVI Benign, at Least to 3 Years

Michael O'Riordan

June 07, 2022

News Daily News

Subclinical Leaflet Thrombosis After TAVI Linked to Higher Mortality

Michael O'Riordan

March 10, 2022

News Daily News

TCTMD’s Top 10 Most Popular Stories for October 2021

Shelley Wood

November 02, 2021

News Daily News

Observational Study Supports Continuing Oral Anticoagulation During PCI

Michael O'Riordan

April 06, 2021

News Daily News

DOACs May Up Post-TAVR Survival in A-fib: OCEAN-TAVI

Caitlin E. Cox

October 29, 2020

News Daily News

New Meta-analysis Supports NOAC Plus P2Y12 Inhibitor for PCI in A-fib

Shelley Wood

February 28, 2020

News Daily News

Bioprosthetic Valve Thrombosis Rare but Not Benign: New Insights

Yael L. Maxwell

February 28, 2020

News Daily News

Switch Anticoagulants for A-fib Patients Needing a Stent? RE-DUAL PCI Insights

Shelley Wood

December 02, 2019

News Daily News

Bleeding Risk Similar for Peripheral, Coronary Revascularization: EUCLID

Caitlin E. Cox

October 16, 2019

Advertisement

AHA/ACC and Others Issue PAD Guideline Update With Focus on Collaborative Care

Ischemic Stroke After LAA Closure May Be Less Severe Than on DOACs

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

Subclinical Thrombosis After TAVI Benign, at Least to 3 Years

Subclinical Leaflet Thrombosis After TAVI Linked to Higher Mortality

TCTMD’s Top 10 Most Popular Stories for October 2021

Observational Study Supports Continuing Oral Anticoagulation During PCI

DOACs May Up Post-TAVR Survival in A-fib: OCEAN-TAVI

New Meta-analysis Supports NOAC Plus P2Y12 Inhibitor for PCI in A-fib

Bioprosthetic Valve Thrombosis Rare but Not Benign: New Insights

Switch Anticoagulants for A-fib Patients Needing a Stent? RE-DUAL PCI Insights

Bleeding Risk Similar for Peripheral, Coronary Revascularization: EUCLID

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content